T he use of complementary and alternative medicines has become increasingly popular in the US. Until recently, most surveys about these therapies have focused on use by patients in the ambulatory care setting. In this issue, two studies examine the use of herbals/alternative medicines in the inpatient population, finding that approximately 20% of an inpatient population and 17.4% of a perioperative population report regular use of alternative medicines. 1, 2 In the study by Leady et al., only 36% of the inpatients reported being asked about alternative medicine use by a health care professional and only 24% of the total survey sample had querying about herbal use documented in their medical charts. 1 Although the Joint Commission on Accreditation of Healthcare Organizations (JCAHO) recommends that alternative supplements be processed in a manner similar to nonprescription drugs in the hospital setting, 3 significant differences between these two groups of medicines remain.
The use of alternative medications in the hospital setting raises several issues related to medication safety. As the Leady et al study indicates, relatively few patients were asked about alternative medicine use during their hospital stays. As the authors suggest, encouraging patients to discuss alternative product use is the first step to appropriate recognition and proper documentation.
Once use is documented, the pharmacy should be notified. Not all hospitals have alternative medicine formularies; thus policies regarding patients' own medication use as they relate to these products should be reviewed. Proper identification of alternative/complementary medicines, which have no mandatory requirements regarding potency, content, etc, can be difficult.
The knowledge base and scientific evidence related to these products is rapidly shifting. Thus, drug information resources required to screen for adverse events and drug interactions are relatively lacking for these products when compared with traditional therapies. The fact that much drug-interaction screening software still lacks comprehensive data on herbal drug interactions means that clinicians must be especially vigilant when such therapies are used by inpatients.
Many hospital pharmacists may be relatively unfamiliar with complementary/alternative medications. Education of the hospital pharmacist regarding alternative medicine use should be initiated, particularly in areas where high use has been documented.
Herbal medicine use is no longer just an outpatient issue. Until further data become available, hospital pharmacists need to develop systems that appropriately track the use of these products and the patient outcomes and adverse reactions related to this use.
